Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan

Morihiko Kimura,Tominaga T,Yuichi Takatsuka,Masakazu Toi,Rikiya Abe,Hiroki Koyama,Shigemitsu Takashima,Nomura Y,Shigeto Miura,Izo Kimijima,Hideya Tashiro,Yasuo Ohashi

Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan

2010

Morihiko Kimura
Tominaga T
Yuichi Takatsuka
Masakazu Toi
Rikiya Abe
Hiroki Koyama
Shigemitsu Takashima
Nomura Y
Shigeto Miura
Izo Kimijima
Hideya Tashiro
Yasuo Ohashi

Background To compare the cyclophosphamide, methotrexate, and fluorouracil (CMF) chemotherapy and the anthracycline-containing regimen cyclophosphamide, epirubicin, and fluorouracil (CEF) to evaluate the efficacy and safety of the latter.

Keywords:

Regimen
Breast cancer
Fluorouracil
Survival rate
Epirubicin
Oncology
Methotrexate
Medicine
Internal medicine
Chemotherapy
Cyclophosphamide

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations